Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes

NCT00605111 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

193

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: biphasic insulin aspart

Sponsor

Novo Nordisk A/S